State-of-the-art MRI technology bypasses need for biopsy

January 3, 2018, UT Southwestern Medical Center
State-of-the-art MRI technology bypasses need for biopsy
Dr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI) protocols that tell physicians with high confidence whether the tumor is aggressive. Credit: UT Southwestern

The most common type of tumor found in the kidney is generally quite small (less than 1.5 in). These tumors are usually found by accident when CAT scans are performed for other reasons and the serendipitous finding poses a problem for doctors. Are these tumors malignant and do they need to be surgically removed because they may threaten the patient's life? Or are they benign and can be left alone?

The decision is often made with a biopsy. By sampling the tumor, doctors are able to determine whether the is benign or malignant. However, biopsies are invasive procedures and not without risks.

Investigators with the Kidney Cancer Program at UT Southwestern Harold C. Simmons Comprehensive Cancer Center have developed a Magnetic Resonance Imaging (MRI) technology that can provide information about the nature and aggressiveness of the cancer without having to perform a biopsy.

The team, led by Drs. Ivan Pedrosa and Jeffrey Cadeddu, co-authors of the study highlighted on the cover of The Journal of Urology, have developed multiparametric MRI (mpMRI) protocols that tell physicians with high confidence whether the tumor is aggressive or not. These protocols allow investigators to evaluate the chemical composition of the tumor without a biopsy. This composition allows doctors to infer what type of cancer it is.

"Using mpMRI, multiple types of images can be obtained from the and each one tells us something about the tissue," said Dr. Ivan Pedrosa, Professor of Radiology and Chief of Magnetic Resonance Imaging.

The standardized diagnostic algorithm is largely based on the appearance of the renal mass on specific MRI images, namely T2-weighted images and those immediately after intravenous (IV) dye reaches the kidney. Other images are also used that indicate whether fat is present in the . Based on the algorithm, physicians can recognize clear cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer, with 80% confidence.

"Using mpMRI, doctors at UT Southwestern have a four-in-five chance of identifying clear cell cancer" said Dr. Pedrosa.

The data collected from this study support the use of mpMRI to reduce the number of biopsies. "Biopsies are not entirely free of pain and discomfort," said Dr. Cadeddu, Professor of Urology and Radiology at UT Southwestern. "Some patients, in fact, choose to observe the cancer simply to avoid the pain of the biopsy," he says.

Investigators at UT Southwestern continue to push the technology and are hoping in the near future to be able to predict not only the type of cancer, but also to tell how aggressive it is. "If we can avoid the anxiety and the fear and the rare, but possible complication of a , I think we're pushing medicine forward," said Dr. Cadeddu.

Explore further: Fusion targeted prostate biopsy proves more accurate in diagnosis of prostate cancer

More information: Noah E. Canvasser et al. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses, The Journal of Urology (2017). DOI: 10.1016/j.juro.2017.04.089

Related Stories

Fusion targeted prostate biopsy proves more accurate in diagnosis of prostate cancer

September 14, 2016
New research confirms that an innovative procedure combining MRI and ultrasound to create a 3-D image of the prostate can more accurately locate suspicious areas and help diagnose whether it's prostate cancer.

International agreement on how to evaluate MRI scans "likely to change how we detect prostate cancer"

October 1, 2015
International radiological bodies have agreed on a standard for how doctors evaluate MRI to confirm a diagnosis of prostate cancer. This promises to reduce the number of over diagnosis of insignificant cancers by to up to ...

Renal mass biopsy accurate for small renal masses

February 17, 2016
(HealthDay)—Renal mass biopsy is accurate for small renal masses (4 cm or less), according to a study published in the March issue of The Journal of Urology.

Simple blood tests can help detect, target cancer: study

June 4, 2016
Blood samples can be just as effective as invasive tissue biopsies in monitoring cancer and can help doctors better prescribe treatment, a study revealed Saturday.

Increasing the odds of prostate cancer detection

July 21, 2016
For three years, Andrew Harder wondered if he had prostate cancer. In 2009, he had routine blood work that revealed an elevated prostate-specific antigen level. When PSA is above 4 nanograms per milliliter of blood, it can ...

Recommended for you

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Experimental arthritis drug prevents stem cell transplant complication

April 24, 2018
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows. ...

Scientists develop a new model for glioblastoma using gene-edited organoids

April 24, 2018
Glioblastoma multiforme (GBM) is an incredibly deadly brain cancer and presents a serious black box challenge. It's virtually impossible to observe how these tumors operate in their natural environment and animal models don't ...

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.